Sophia Delicou: Mediterranean Network for Haemoglobinopathies and Regional Collaboration
Sophia Delicou, Head of Thalassemia and Sickle Cell Unit, Head of the Expertise Center of Hemoglobin Diseases and Their Complications at Hippokrateio General Hospital, shared a post on LinkedIn:
“A meaningful step forward for the haemoglobinopathy community in the Mediterranean.
It was a great pleasure to be in Rome for the launch of the Mediterranean Network for Haemoglobinopathies, bringing together leading experts, patient representatives and organisations with a shared commitment to stronger regional collaboration.
As stated in the founding Declaration, the Network aims to develop as a collaborative, patient-centred, evidence-informed and independent platform for regional cooperation.
The discussions highlighted some of the key priorities ahead: improving understanding of patient distribution, raising awareness among healthcare professionals and patients, ensuring access to standards of care, expanding access to innovation and specialised centres, and strengthening dialogue with policymakers.
It was a privilege to exchange perspectives with distinguished leaders in the field, including Prof. Maria Domenica Cappellini, Prof. Antonio Piga and Dr. Androulla Eleftheriou, among many other colleagues dedicated to improving outcomes for people living with haemoglobinopathies.
A promising beginning for a collaboration built around a common vision: equitable access to optimal care and the best possible quality of life for every person living with a haemoglobinopathy.”
Other posts featuring Sophia Delicou on Hemostasis Today.
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion
-
Sep 16, 2026, 13:11New Clinical Guidelines for Iron Deficiency from ASH
-
Sep 16, 2026, 13:03Khushboo Lakhera: Sharing One Purpose with Blood Donation Camp